SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-039677
Filing Date
2021-02-12
Accepted
2021-02-12 06:07:28
Documents
2
Group Members
GILBERT H. KLIMANINTERWEST MANAGEMENT PARTNERS X, LLCKEVAL DESAIKHALED A. NASR

Document Format Files

Seq Description Document Type Size
1 SC 13G d125958dsc13g.htm SC 13G 107150
2 EX-99.A d125958dex99a.htm EX-99.A 5249
  Complete submission text file 0001193125-21-039677.txt   113990
Mailing Address C/O INTERWEST PARTNERS 467 FIRST STREET SUITE 201 LOS ALTOS CA 94022
Business Address C/O INTERWEST PARTNERS 467 FIRST STREET SUITE 201 LOS ALTOS CA 94022 650-854-8585
INTERWEST PARTNERS X LP (Filed by) CIK: 0001443898 (see all company filings)

IRS No.: 263131621
Type: SC 13G

Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Subject) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91714 | Film No.: 21622525
SIC: 2834 Pharmaceutical Preparations